---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-075310"
form_type: "8-K"
ticker: "ZBH"
cik: "0001136869"
company_name: "ZIMMER BIOMET HOLDINGS, INC."
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:14:10.461141+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Zimmer Biomet appoints Embecta CEO Devdatt Kurdikar to Board of Directors

## Summary
- Board expanded from 10 to 11 members; Devdatt Kurdikar appointed effective June 20, 2024.
- Kurdikar serves as President & CEO of Embecta Corp. (Nasdaq: EMBC), a diabetes management spinoff from BD.
- He will serve on the Corporate Governance Committee and Compensation & Management Development Committee.
- His term expires at the 2025 annual meeting; standard non-employee director compensation applies.
- No arrangements or material interests disclosed; indemnification agreement expected.

## SEC filing metadata
- accession: 0000950170-24-075310
- form_type: 8-K
- ticker: ZBH
- cik: 0001136869
- company_name: ZIMMER BIOMET HOLDINGS, INC.
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1136869/000095017024075310/0000950170-24-075310-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1136869/000095017024075310/zbh-20240620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-075310
- JSON: https://secwatch.observer/filing/0000950170-24-075310.json
- Plain text: https://secwatch.observer/filing/0000950170-24-075310.txt

## Key facts
- Executive change
  Devdatt Kurdikar was appointed as Director at ZIMMER BIOMET HOLDINGS, INC..
  - Action: appointed
  - Role: Director
  source text: On June 20, 2024, the Board of Directors (the “Board”) of Zimmer Biomet Holdings, Inc. (the “Company”), upon the recommendation of the Corporate Governance Committee, increased the size of the Board from ten members to eleven members and appointed Devdatt Kurdikar to fill the resulting vacancy
  evidence_url: https://www.sec.gov/Archives/edgar/data/1136869/000095017024075310/0000950170-24-075310-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.